Filing Details

Accession Number:
0001181431-10-009620
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-17 12:00:00
Reporting Period:
2010-02-16
Filing Date:
2010-02-17
Accepted Time:
2010-02-17 15:45:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722104 Savient Pharmaceuticals Inc SVNT Medicinal Chemicals & Botanical Products (2833) 133033811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456864 David Gionco Savient Pharmaceuticals, Inc.
One Tower Center, 14Th Floor
East Brunswick NJ 08816
Group Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Per Share Disposition 2010-02-16 1,253 $13.81 31,155 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on Feb 14, 2008.